| GO ID | GO name | Interaction type | Reference |
|---|---|---|---|
| GO:0000737 | Dna catabolic process, endonucleolytic | Increases phenotype | PMID:12160896; PMID:39400474; PMID:39843243 |
| GO:0002523 | Leukocyte migration involved in inflammatory response | Increases phenotype | PMID:39400474; PMID:39843243 |
| GO:0003990 | Acetylcholinesterase activity | Increases phenotype | PMID:39400474; PMID:39843243 |
| GO:0004096 | Catalase activity | Decreases phenotype | PMID:39400474; PMID:39843243 |
| GO:0004364 | Glutathione transferase activity | Decreases phenotype | PMID:39400474; PMID:39600142; PMID:39843243 |
| GO:0004457 | Lactate dehydrogenase activity | Increases phenotype | PMID:39400474; PMID:39600142; PMID:39843243 |
| GO:0004784 | Superoxide dismutase activity | Decreases phenotype | PMID:39400474; PMID:39843243 |
| GO:0006979 | Response to oxidative stress | Affects phenotype | PMID:33748463 |
| GO:0007283 | Spermatogenesis | Affects phenotype | PMID:33565293 |
| GO:0007612 | Learning | Decreases phenotype | PMID:551301; PMID:7464455 |
| GO:0007613 | Memory | Decreases phenotype | PMID:33748463 |
| GO:0007626 | Locomotory behavior | Affects phenotype | PMID:551301; PMID:7464455 |
| GO:0008219 | Cell death | Increases phenotype | PMID:7953637 |
| GO:0008283 | Cell population proliferation | Increases phenotype | PMID:39843243 |
| GO:0010730 | Negative regulation of hydrogen peroxide biosynthetic process | Increases phenotype | PMID:39600142 |
| GO:0015734 | Taurine transport | Decreases phenotype | PMID:39341 |
| GO:0015816 | Glycine transport | Decreases phenotype | PMID:39341 |
| GO:0015871 | Choline transport | Decreases phenotype | PMID:39341 |
| GO:0019627 | Urea metabolic process | Affects phenotype | PMID:32981412 |
| GO:0031987 | Locomotion involved in locomotory behavior | Affects phenotype | PMID:22323474 |
| GO:0032099 | Negative regulation of appetite | Increases phenotype | PMID:6146662 |
| GO:0032125 | Micronucleus organization | Increases phenotype | PMID:22847138 |
| GO:0034440 | Lipid oxidation | Increases phenotype | PMID:39400474 |
| GO:0035640 | Exploration behavior | Decreases phenotype | PMID:19264092 |
| GO:0040013 | Negative regulation of locomotion | Increases phenotype | PMID:6146662 |
| GO:0042428 | Serotonin metabolic process | Affects phenotype | PMID:19264092 |
| GO:0042743 | Hydrogen peroxide metabolic process | Increases phenotype | PMID:39400474 |
| GO:0044782 | Cilium organization | Affects phenotype | PMID:24941295 |
| GO:0046449 | Creatinine metabolic process | Affects phenotype | PMID:32981412 |
| GO:0046959 | Habituation | Decreases phenotype | PMID:551301 |
| GO:0050996 | Positive regulation of lipid catabolic process | Increases phenotype | PMID:39600142 |
| GO:0051612 | Negative regulation of serotonin uptake | Increases phenotype | PMID:39341 |
| GO:0051622 | Negative regulation of norepinephrine uptake | Increases phenotype | PMID:39341 |
| GO:0051782 | Negative regulation of cell division | Increases phenotype | PMID:20667460 |
| GO:0051938 | L-glutamate import | Decreases phenotype | PMID:39341 |
| GO:0051939 | Gamma-aminobutyric acid import | Decreases phenotype | PMID:39341 |
| GO:0061370 | Testosterone biosynthetic process | Affects phenotype | PMID:33565293 |
| GO:0061533 | Norepinephrine secretion, neurotransmission | Increases phenotype | PMID:6146388 |
| GO:0061534 | Gamma-aminobutyric acid secretion, neurotransmission | Increases phenotype | PMID:6146388 |
| GO:0061744 | Motor behavior | Decreases phenotype | PMID:19264092 |
| GO:0070265 | Necrotic cell death | Increases phenotype | PMID:39400474; PMID:39843243 |
| GO:0070588 | Calcium ion transmembrane transport | Decreases phenotype | PMID:6098274 |
| GO:0070994 | Detection of oxidative stress | Increases phenotype | PMID:39843243 |
| GO:0090494 | Dopamine uptake | Decreases phenotype | PMID:451609 |
| GO:1901668 | Regulation of superoxide dismutase activity | Affects phenotype | PMID:39600142 |
| GO:1902552 | Negative regulation of catalase activity | Increases phenotype | PMID:39600142 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.